Menatetrenone (vitamin K2) and bone quality in the treatment of postmenopausal osteoporosis.

@article{Iwamoto2006MenatetrenoneK,
  title={Menatetrenone (vitamin K2) and bone quality in the treatment of postmenopausal osteoporosis.},
  author={Jun Iwamoto and Tsuyoshi Takeda and Yoshihiro Sato},
  journal={Nutrition reviews},
  year={2006},
  volume={64 12},
  pages={509-17}
}
Menatetrenone (vitamin K2) reduces the incidence of vertebral fractures but has only modest effects on bone mineral density (BMD) in postmenopausal women with osteoporosis. Combined treatment with bisphosphonates and menatetrenone may be more effective than treatment with bisphosphonates alone in preventing vertebral fractures, despite the lack of an additive effect of menatetrenone on the BMD increase by bisphosphonates. Menatetrenone improves bone architecture in ovariectomized rats, and the… CONTINUE READING
9 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…